U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826560) titled 'Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD' on May 31, 2022.
Brief Summary: COPD is a significant health problem worldwide. It affects more than 10% of patients over the age of 40. According to the World Health Organization, it is the third most common cause of death among adults in the world, and the number of patients is continuously growing. Hence, all measures aimed at a better understanding of COPD pathogenesis, the course of the disease, and limitations in treatment efficacy seem critically important. Since 2008 our team has provided a substantial output in understanding the pathophysiology o...